ClearPoint Neuro, Inc. Income Statement
CLPT|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$37M
FY2025
Gross Profit
$23M
61.4% gross margin
Operating Income
-$24M
FY2025
Net Income
-$26M
FY2025
ClearPoint Neuro, Inc. reported $37M in revenue and $26M in net loss for FY2025. Revenue has grown at a 16.5% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37.0M | $24.0M | $24.0M | $20.6M | $16.3M | $12.8M | $11.2M | $7.4M | $7.4M | $5.7M | $4.6M | $3.6M | $5.1M | $5.1M |
| Cost of Revenue | $14.3M | $10.3M | $10.3M | $7.0M | $5.2M | $3.7M | $3.9M | $2.4M | $2.9M | $2.6M | $2.0M | $1.9M | $555.7K | $555.7K |
| Gross Profit | $22.7M | $13.6M | $13.6M | $13.5M | $11.1M | $9.1M | - | - | - | - | - | - | - | - |
| SG&A Expense | $16.5M | $11.8M | $11.8M | $9.6M | $8.0M | $5.3M | $4.3M | $4.3M | $4.0M | $4.2M | $8.4M | $8.0M | $6.0M | $6.0M |
| R&D Expense | $13.9M | $11.7M | $11.7M | $10.9M | $9.3M | $4.7M | $2.8M | $2.3M | $2.8M | $2.6M | $2.0M | $3.3M | $2.5M | $2.5M |
| Operating Income | -$24.2M | -$22.4M | -$22.4M | -$16.3M | -$13.4M | -$6.2M | -$4.6M | -$5.2M | -$6.3M | -$7.5M | -$9.0M | -$5.3M | -$3.1M | -$3.1M |
| Interest Expense | - | $386.0K | - | $81.0K | $973.0K | $1.4M | $955.0K | $980.4K | $872.9K | $1.1M | $1.3M | $1.0M | $2.6M | $2.6M |
| Income Tax | $55.0K | $8.0K | $8.0K | $0 | $0 | $0 | - | - | - | - | - | $0 | $0 | $0 |
| Net Income | -$25.5M | -$22.1M | -$22.1M | -$16.4M | -$14.4M | -$6.8M | -$5.5M | -$6.2M | -$7.2M | -$8.1M | -$8.4M | -$4.5M | -$5.9M | -$5.9M |
| EPS (Basic) | -$0.70 | -$0.90 | -$0.68 | -$0.69 | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$0.70 | -$0.90 | -$0.68 | -$0.69 | -$0.43 | -$0.42 | -$0.56 | -$0.93 | -$2.93 | -$4.48 | -$0.08 | -$0.12 | -$0.15 | -$1.40 |
| Shares Outstanding | 27.6M | 24.7M | 24.6M | 23.7M | 17.0M | 15.2M | 11.0M | 10.7M | 3.6M | 2.3M | 74.8M | 58.5M | 48.1M | 16.1M |
| Gross Margin | 61.4% | 56.8% | 56.8% | 65.8% | 68.2% | 71.1% | - | - | - | - | - | - | - | - |
| Operating Margin | -65.4% | -93.7% | -93.7% | -79.5% | -82.0% | -48.5% | -41.0% | -71.4% | -85.9% | -130.3% | -195.3% | -147.6% | -61.9% | -61.9% |
| Profit Margin | -69.1% | -92.2% | -92.2% | -80.0% | -88.4% | -52.9% | -49.4% | -83.8% | -97.1% | -140.4% | -183.9% | -125.5% | -116.2% | -116.2% |